- Home
- CMTL vs ANVS Comparison
CMTL vs ANVS Comparison
Compare CMTL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- ANVS
- Stock Information
- Founded
- CMTL 1967
- ANVS 2008
- Country
- CMTL United States
- ANVS United States
- Employees
- CMTL N/A
- ANVS N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- ANVS Health Care
- Exchange
- CMTL Nasdaq
- ANVS Nasdaq
- Market Cap
- CMTL 64.4M
- ANVS 53.3M
- IPO Year
- CMTL N/A
- ANVS 2020
- Fundamental
- Price
- CMTL $3.03
- ANVS $5.03
- Analyst Decision
- CMTL Strong Buy
- ANVS Strong Buy
- Analyst Count
- CMTL 1
- ANVS 3
- Target Price
- CMTL $6.00
- ANVS $13.50
- AVG Volume (30 Days)
- CMTL 297.2K
- ANVS 3.6M
- Earning Date
- CMTL 11-10-2025
- ANVS 11-12-2025
- Dividend Yield
- CMTL N/A
- ANVS N/A
- EPS Growth
- CMTL N/A
- ANVS N/A
- EPS
- CMTL N/A
- ANVS N/A
- Revenue
- CMTL $499,528,000.00
- ANVS N/A
- Revenue This Year
- CMTL N/A
- ANVS N/A
- Revenue Next Year
- CMTL $5.15
- ANVS N/A
- P/E Ratio
- CMTL N/A
- ANVS N/A
- Revenue Growth
- CMTL N/A
- ANVS N/A
- 52 Week Low
- CMTL $1.19
- ANVS $1.11
- 52 Week High
- CMTL $4.88
- ANVS $7.39
- Technical
- Relative Strength Index (RSI)
- CMTL 50.88
- ANVS 85.80
- Support Level
- CMTL $2.72
- ANVS $2.11
- Resistance Level
- CMTL $3.50
- ANVS $4.00
- Average True Range (ATR)
- CMTL 0.25
- ANVS 0.57
- MACD
- CMTL -0.02
- ANVS 0.26
- Stochastic Oscillator
- CMTL 41.03
- ANVS 87.57
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.